Ablation of Peroxiredoxin II Attenuates Experimental Colitis by Increasing FoxO1-Induced Foxp3+ Regulatory T Cells
Authors:
Open Access
- 15 October 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 191 (8) , 4029-4037
Abstract
Peroxiredoxin (Prx) II is an intracellular antioxidant molecule that eliminates hydrogen peroxide, employing a high substrate-binding affinity. PrxII deficiency increases the levels of intracellular reactive oxygen species in many types of cells, which may increase reactive oxygen species–mediated inflammation. In this study, we investigated the susceptibility of PrxII knockout (KO) mice to experimentally induced colitis and the effects of PrxII on the immune system. Wild-type mice displayed pronounced weight loss, high mortality, and colon shortening after dextran sulfate sodium administration, whereas colonic inflammation was significantly attenuated in PrxII KO mice. Although macrophages were hyperactivated in PrxII KO mice, the amount of IFN-γ and IL-17 produced by CD4+ T cells was substantially reduced. Foxp3+ regulatory T (Treg) cells were elevated, and Foxp3 protein expression was increased in the absence of PrxII in vitro and in vivo. Restoration of PrxII into KO cells suppressed the increased Foxp3 expression. Interestingly, endogenous PrxII was inactivated through hyperoxidation during Treg cell development. Furthermore, PrxII deficiency stabilized FoxO1 expression by reducing mouse double minute 2 homolog expression and subsequently activated FoxO1-mediated Foxp3 gene transcription. PrxII overexpression, in contrast, reduced FoxO1 and Foxp3 expression. More interestingly, adoptive transfer of naive CD4+ T cells from PrxII KO mice into immune-deficient mice attenuated T cell–induced colitis, with a reduction in mouse double minute 2 homolog expression and an increase in FoxO1 and Foxp3 expression. These results suggest that inactivation of PrxII is important for the stability of FoxO1 protein, which subsequently mediates Foxp3+ Treg cell development, thereby attenuating colonic inflammation.Keywords
This publication has 47 references indexed in Scilit:
- Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage SpecificationCell, 2012
- Protective and pathogenic functions of macrophage subsetsNature Reviews Immunology, 2011
- Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cellsProceedings of the National Academy of Sciences, 2011
- Foxo Transcription Factors Control Regulatory T Cell Development and FunctionImmunity, 2010
- Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cellsJournal of Experimental Medicine, 2010
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and DegradationJournal of Biological Chemistry, 2009
- CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylationJournal of Experimental Medicine, 2007
- Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shockJournal of Experimental Medicine, 2007
- PeroxiredoxinsBiological Chemistry, 2002